CD4 and relapsing-remitting multiple sclerosis: This finding suggested that RRMS patients have increased naïve CD4 T-cell homeostatic proliferation [23]; an increase in thymocyte proliferation seems an unlikely explanation of the reduced βTRECs, as such proliferation is inconsistent with thymic involutional processes [30, 31].